Nature, nurture and neurobiology: Gene-environment interactions in neuropsychiatric disorders

Neurobiology of Disease

Volumn 57, Issue , 2013, Pages 1-4

  Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Anxiety; Bipolar disorder; Cognitive activity; Dementia; Depression; Disease modifiers; Environmental factors; Experience dependent plasticity; Genetic factors; Huntington's disease; Mood disorders; Neurological diseases; Parkinson's disease; Physical exercise; Psychiatric disorders; Psychoses; Schizophrenia; Stress; Therapeutics

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; DAILY LIFE ACTIVITY; DEPRESSION; DOWN SYNDROME; EDITORIAL; ENVIRONMENTAL ENRICHMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPILEPSY; FRAGILE X SYNDROME; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; NATURAL SCIENCE; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPSYCHIATRY; NONHUMAN; PARKINSON DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RETT SYNDROME; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

GENE-ENVIRONMENT INTERACTION; HUMANS; MENTAL DISORDERS; NEUROBIOLOGY;

EID: 84879780064     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.01.004     Document Type: Editorial

References (44)

1. Ahlskog J.E. Does vigorous exercise have a neuroprotective effect in Parkinson disease?. Neurology 2011, 77:288-294.
2. Burrows, E.L., Hannan, A.J., in press. Towards environmental construct validity in animal models of CNS disorders: optimizing translation of preclinical studies. CNS Neurol. Disord. Drug Targets. (Epub ahead of print).
3. Burrows E.L., McOmish C.E., Hannan A.J. Gene-environment interactions and construct validity in preclinical models of psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1376-1382.
4. Cannon J.R., Greenamyre J.T. Gene-environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models. Neurobiol. Dis. 2013, 57:38-46. (this issue).
5. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
6. Dierssen M., Benavides-Piccione R., Martínez-Cué C., Estivill X., Flórez J., Elston G.N., et al. Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment. Cereb. Cortex 2003, 13:758-764.
7. Duman R.S., Malberg J., Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 1999, 46:1181-1191.
8. Eisch A.J., Cameron H.A., Encinas J.M., Meltzer L.A., Ming G.L., Overstreet-Wadiche L.S. Adult neurogenesis, mental health, and mental illness: hope or hype?. J. Neurosci. 2008, 28:11785-11791.
9. Gray, J.D., Milner, T.A., McEwen, B.S., in press. Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience (Aug 23) (doi:pii: S0306-4522(12)00861-5). http://dx.doi.org/10.1016/j.neuroscience.2012.08.034.
10. Grote H.E., Bull N.D., Howard M.L., van Dellen A., Blakemore C., Bartlett P.F., et al. Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur. J. Neurosci. 2005, 22:2081-2088.
11. Hannan A.J. Tandem repeat polymorphisms: modulators of disease susceptibility and candidates for 'missing heritability'. Trends Genet. 2009, 26:59-65.
12. Intlekofer K.A., Cotman C.W. Exercise counteracts declining hippocampal function in aging and Alzheimer's disease. Neurobiol. Dis. 2013, 57:47-55. (this issue).
13. Jacobs B.L., van Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 2000, 5:262-269.
14. Jankowsky J.L., Melnikova T., Fadale D.J., Xu G.M., Slunt H.H., Gonzales V., et al. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 2005, 25:5217-5224.
15. Kempermann G., Kuhn H.G., Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386:493-495.
16. Kondo M., Gray L.J., Pelka G.J., Christodoulou J., Tam P.P., Hannan A.J. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome-Mecp2 gene dosage effects and BDNF expression. Eur. J. Neurosci. 2008, 27:3342-3350.
17. Landis S.C., Amara S.G., Asadullah K., Austin C.P., Blumenstein R., Bradley E.W., et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012, 490:187-191.
18. Laviola G., Hannan A.J., Macrì S., Solinas M., Jaber M. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol. Dis. 2008, 31:159-168.
19. Levi O., Jongen-Relo A.L., Feldon J., Roses A.D., Michaelson D.M. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 2003, 13:273-282.
20. Lin C.Y., Sawa A., Jaaro-Peled H. Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models. Neurobiol. Dis. 2012, 45:48-56.
21. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003, 28:1562-1571.
22. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
23. Manno I., Macchi F., Caleo M., Bozzi Y. Environmental enrichment reduces spontaneous seizures in the Q54 transgenic mouse model of temporal lobe epilepsy. Epilepsia 2011, 52:e113-e117.
24. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
25. McGrath J.J., Hannan A.J., Gibson G. Decanalization, brain development and risk of schizophrenia. Transl. Psychiatry 2011, 1:e14.
26. McOmish C.E., Hannan A.J. Enviromimetics: exploring gene-environment interactions to identify therapeutic targets for brain disorders. Expert Opin. Ther. Targets 2007, 11:899-913.
27. McOmish C.E., Burrows E., Howard M., Scarr E., Kim D., Shin H.S., et al. Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol. Psychiatry 2007, 13:661-672.
28. Nithianantharajah J., Hannan A.J. The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Prog. Neurobiol. 2009, 89:369-382.
29. Ota K.T., Duman R.S. Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression. Neurobiol. Dis. 2013, 57:28-37. (this issue).
30. Perera T.D., Dwork A.J., Keegan K.A., Thirumangalakudi L., Lipira C.M., Joyce N., et al. Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One 2011, 6:e17600.
31. Pletnikov M.V., Sawa A., Kannan G. Mouse models of gene-environment interactions in schizophrenia. Neurobiol. Dis. 2013, 57:5-11. (this issue).
32. Reitz C., Brayne C., Mayeux R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 2011, 7:137-152.
33. Renoir T., Pang T.Y., Hannan A.J. Effects of environmental manipulations in genetically targeted animal models of affective disorders. Neurobiol. Dis. 2013, 57:12-27. (this issue).
34. Restivo L., Ferrari F., Passino E., Sgobio C., Bock J., Oostra B.A., et al. Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11557-11562.
35. Samuels B.A., Hen R. Neurogenesis and affective disorders. Eur. J. Neurosci. 2011, 33:1152-1159.
36. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
37. Stam N.C., Nithianantharajah J., Howard M.L., Atkin J.D., Cheema S.S., Hannan A.J. Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2008, 28:717-723.
38. Surget A., Tanti A., Leonardo E.D., Laugeray A., Rainer Q., Touma C., et al. Antidepressants recruit new neurons to improve stress response regulation. Mol. Psychiatry 2011, 16:1177-1188.
39. Thomas R.M., Hotsenpiller G., Peterson D.A. Acute psychosocial stress reduces cell survival in adult hippocampal neurogenesis without altering proliferation. J. Neurosci. 2007, 27:2734-2743.
40. Trembath M.K., Horton Z.A., Tippett L., Hogg V., Collins V.R., Churchyard A., et al. A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov. Disord. 2010, 25:1444-1450.
41. van Dellen A., Blakemore C., Deacon R., York D., Hannan A.J. Delaying the onset of Huntington's in mice. Nature 2000, 404:721-722.
42. van Dongen J., Slagboom P.E., Draisma H.H., Martin N.G., Boomsma D.I. The continuing value of twin studies in the omics era. Nat. Rev. Genet. 2012, 13:640-653.
43. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999, 2:266-270.
44. Wexler N.S., Lorimer J., Porter J., Gomez F., Moskowitz C., Shackell E. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3498-3503. U.S.-Venezuela Collaborative Research Project.